Designed to make market research more actionable and strategically valuable, The Business Research Company’s 2026 market reports feature market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights.
Drug-Delivery Technology Market Revenue Expansion Outlook For The 2026–2030 Forecast Period
The drug-delivery technology market has experienced substantial growth in recent years. It is forecast to expand from $54.24 billion in 2025 to $60.27 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.1%. This historic expansion can be attributed to an increase in chronic diseases, innovations in pharmaceutical formulations, a rising demand for improved patient compliance, the broader adoption of injectable therapies, and advancements in medical devices.
The drug-delivery technology market is projected to experience substantial expansion over the coming years, reaching $91.41 billion by 2030, driven by an impressive compound annual growth rate (CAGR) of 11.0%. This anticipated growth during the forecast period is fueled by several factors, including the emergence of personalized medicine, the proliferation of biologics and biosimilars, a rising need for long-acting drug delivery methods, advancements in implantable technologies, and the increasing acceptance of home care treatment. Key trends expected during this period encompass targeted drug delivery systems, formulations designed for controlled and sustained release, patient-centric drug delivery devices, minimally invasive delivery approaches, and sophisticated implantable drug systems.
Download A Free Sample For In-Depth Drug-Delivery Technology Market Intelligence:
Drug-Delivery Technology Market Demand Driver: How It Is Shaping Industry Growth
The rising incidence of chronic ailments is projected to stimulate the expansion of the drug-delivery technology market. These are enduring medical conditions that typically advance slowly and demand continuous management. The heightened occurrence of chronic diseases stems from inactive lifestyles, which diminish physical activity and contribute to obesity and related health concerns. Drug-delivery technology enhances the management of chronic diseases by enabling targeted medication delivery, controlled release, improved absorption, and minimized adverse effects, thereby boosting treatment effectiveness, patient compliance, and overall disease management. For instance, in July 2024, according to the Australian Burden of Disease Study 2023 by the Australian Institute of Health and Welfare (AIHW), chronic conditions constituted 91% of the non-fatal burden (years lived with disability) and 78% of the fatal burden (years of life lost) in 2023. Therefore, the expanding prevalence of chronic diseases is propelling the growth of the drug-delivery technology market.
Drug-Delivery Technology Market Segmentation Overview: Detailed Category Analysis
The drug-delivery technology market covered in this report is segmented –
1) By Type: Oral, Injectable, Topical, Ocular, Nasal, Pulmonary, Transmucosal, Implantable
2) By Application: Cardiovascular Diseases, Oncology, Urology, Diabetes, Central Nervous System (CNS), Ophthalmology, Infections, Other Applications
3) By End User: Hospitals, Clinics, Diagnostic Centers, Home Care Settings, Other End Users
Subsegments:
1) By Oral: Tablets, Capsules, Solutions, Suspensions, Powders, Gels
2) By Injectable: Conventional Injection, Self-Injection, Long-Acting Injection
3) By Topical: Creams, Gels, Lotions, Patches, Ointments
4) By Ocular: Eye Drops, Ointments, Gels, Inserts, Implants
5) By Nasal: Sprays, Drops, Powders, Gels
6) By Pulmonary: Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers
7) By Transmucosal: Buccal, Sublingual, Rectal, Vaginal
8) By Implantable: Biodegradable Implants, Non-Biodegradable Implants, Drug-Eluting Stents
Top Drug-Delivery Technology Market Trends And Recent Industry Developments
Leading companies within the drug-delivery technology market are focusing on developing innovative products, such as prefilled injection devices, to enhance patient convenience, improve dosing accuracy, and ensure safer drug administration. A prefilled injection device is a medical instrument that comes preloaded with a specific dose of medication, thereby eliminating the need for manual drug filling before its use. For instance, in February 2023, Phillips-Medisize LLC, a US-based medical equipment manufacturing company, launched a new disposable pen injector designed for high-volume manufacturing. This injector features a compact and flexible design with customizable dosing and push-button colors to support multiple therapies, including diabetes, fertility, growth hormones, obesity, and osteoporosis. The device aims to help pharmaceutical companies accelerate market entry by offering a cost-effective, ready-to-use solution while reducing commercialization costs and risks.
Drug-Delivery Technology Market Company Landscape: Key Players To Watch
Major companies operating in the drug-delivery technology market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc., Cipla Limited, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, Chiesi Farmaceutici S.p.A., United Therapeutics Corporation, Mallinckrodt Pharmaceuticals Plc., Lupin Pharmaceuticals, Inc., Glenmark Pharmaceuticals Limited, Alkermes plc., Halozyme Therapeutics Inc., Sunovion Pharmaceuticals Inc., and Circassia Pharmaceuticals Plc.
Explore The Drug-Delivery Technology Global Market Report For Full Insights:
Drug-Delivery Technology Market Region-Wise Analysis: Largest Regional Market Identified
North America was the largest region in the drug-delivery technology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug-delivery technology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
